Fresenius | FRE - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Akzo Nobel EUR 4.85B 28M 2026-06
Alcon AG USD 21.6B 538M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
BASF EUR 36.32B 846M 2026-06
Bayer EUR 29.71B 863M 2026-06
Beiersdorf EUR 8.6B 133M 2025-12
DaVita Healthcare Partners USD -765.1M 9.6M 2026-06
Demant DKK 11.24B 1.4B 2026-06
E.ON EUR 21.22B 7.6B 2026-06
Essilor EUR 39.22B 329M 2026-06
Fresenius EUR 19.7B 766M 2026-06
Fresenius Medical Care EUR 13.53B 673.44M 2026-06
Getinge SEK 30.94B 2.06B 2026-06
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
GN Store Nord DKK 10.12B 4.76B 2026-03
GRIFOLS EUR 7.98B 2.52B 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 30.17B 430M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Philips EUR 11.48B 84M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
RWE EUR 39.62B 3.2B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Smith & Nephew USD 5.18B 356M 2026-06